Company intelligence / Profile preview

Neuria Digital Therapeutics

Fribourg / Lausanne*, Fribourg canton / Vaud canton*, Switzerland

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship game “The Diner” demonstrated a reduction in cravings and actual consumption of unhealthy foods by approximately 20% among participants. Their MVP has shown significant reductions in sugar consumption. They are preparing for regulatory approval as a medical device and commercial launch.

Therapeutic areas: Metabolic DisordersPsychiatryOther
Modalities: Non-pharmacological therapy (digital intervention)Device (software-based digital therapeutic)Game-based therapy
Industry: Digital Health Medical Devices

Partnerships

Vanguard Accelerator program (business development support)

Beyond the preview

Go deeper on Neuria Digital Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuria Digital Therapeutics.

Explore the full profile